Monoclonal Antibodies That Neutralize Anthrax Protective Antigen (PA) Toxin Read more about Monoclonal Antibodies That Neutralize Anthrax Protective Antigen (PA) Toxin US Patent 10,227,395Filed on 2014-02-14
Influenza Hemagglutinin And Neuraminidase Variants Read more about Influenza Hemagglutinin And Neuraminidase Variants US Patent 9,119,812Filed on 2013-11-21
HIV THERAPEUTICS AND METHODS OF MAKING AND USING SAME Read more about HIV THERAPEUTICS AND METHODS OF MAKING AND USING SAME Patent Cooperation TreatyPCT/US2013/074801Filed on 2013-12-12
DEVELOPMENT OF MUTATIONS USEFUL FOR ATTENUATING DENGUE VIRUSES AND CHIMERIC DENGUE VIRUSES Read more about DEVELOPMENT OF MUTATIONS USEFUL FOR ATTENUATING DENGUE VIRUSES AND CHIMERIC DENGUE VIRUSES US Patent 9,707,287Filed on 2013-12-04
Inhibitors of the Plasmodial Surface Anion Channel as Antimalarials Read more about Inhibitors of the Plasmodial Surface Anion Channel as Antimalarials US Patent 9,394,316Filed on 2013-12-03
Lutzomyia Longipalpis Polypeptides and Methods of Use Read more about Lutzomyia Longipalpis Polypeptides and Methods of Use Italy09158294.0Filed on 2009-04-20
Lutzomyia Longipalpis Polypeptides and Methods of Use Read more about Lutzomyia Longipalpis Polypeptides and Methods of Use France09158294.0Filed on 2009-04-20
Lutzomyia Longipalpis Polypeptides and Methods of Use Read more about Lutzomyia Longipalpis Polypeptides and Methods of Use Spain09158294.0Filed on 2009-04-20
Recovery of Recombinant Human Parainflunza Virus Type 2 (HPIV2) from cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens Read more about Recovery of Recombinant Human Parainflunza Virus Type 2 (HPIV2) from cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens Ireland03752537.5Filed on 2003-09-18
Recovery of Recombinant Human Parainflunza Virus Type 2 (HPIV2) from cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens Read more about Recovery of Recombinant Human Parainflunza Virus Type 2 (HPIV2) from cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens United Kingdom03752537.5Filed on 2003-09-18